Disclosed is a medical agent which selectively stimulates a β3-adrenergic receptor, in particular, a medical agent which is capable of preferentially stimulating a β3-adrenergic receptor in comparison to the case with an α1-adrenergic receptor. The medical agent is able to be used for treatment and prevention of diabetes, obesity, hyperlipemia, depression, cholelithiasis, diseases caused by biliary hyperkinesia, diseases caused by hyperfunction of the digestive tract, interstitial cystitis, overactive bladder, urinary incontinence, or diseases associated with lacrimal hyposecretion.Specifically disclosed is an indazole analogue represented by general formula (I) or a salt thereof. Also specifically disclosed is a pharmaceutical product which contains the indazole analogue or a salt thereof as an active ingredient.
